A shorter, and less toxic treatment for people with visceral leishmaniasis was shown to be effective thanks to a study conducted in Eastern Africa by the non-profit medical research organization Drugs ...

The parasitic disease leishmaniasis is found primarily in Central and South America, the Mediterranean region, the Middle East, and Central Asia and is transmitted to humans by a sand fly. An ...

Researchers in developing countries are trying to find treatments for conditions that affect the poorest people. But the system is stacked against their therapies. By Stephanie Nolen Stephanie Nolen, ...

Leishmaniasis, a neglected tropical disease prevalent across 90 countries, affects approximately 12 million people worldwide, with 350 million more at risk of infection. Caused by unicellular ...

The other two are cutaneous leishmaniasis (the most prevalent, resulting in skin ulcers) and mucocutaneous leishmaniasis (affecting the mouth, nose, and throat). The existing treatments, which mostly ...

Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite. Predominantly affecting vulnerable populations in ...

These natural compounds were isolated from a marine sponge species (Theonella sp.) in Okinawa and then shown to have potent activity against the Leishmania major parasite, which often causes a ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...